This story has been updated from a previous version posted May 26 to include information from the court documents.

Australian genetic testing company Genetic Technologies has sued 10 firms, including 454 Life Sciences, for infringing a patent it holds on method to determine haplotype information from non-coding DNA.

The other firms named in the suit, which was filed this week in the US District Court for the District of Colorado, are Agilent, Bristol-Myers Squibb, Eurofins, GlaxoSmithKline, Hologic, Merial, Navigenics, Neogen, and Pfizer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.